Report #2871874

Received Nov 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 56 yrs
State: TX
Recovered: Unknown
Vaccinated: Sep 11, 2025
Onset: Sep 11, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPAB	HEP A + HEP B (TWINRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	P2443	—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

1st one October 16th, 2021, 2nd one September 11th, 2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 56-year-old male patient who received HAB (Twinrix) (batch number P2443, expiry date 18-SEP-2027) for prophylaxis. Previously administered products included Twinrix (First dose received on 16-OCT-2021, Lot number X239D and Expiry date: 07-AUG-2021). On 11-SEP-2025, the patient received the 2nd dose of Twinrix. On 11-SEP-2025, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: 1st one October 16th, 2021, 2nd one September 11th, 2025). The outcome of the drug dose administration interval too long was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-Nov-2025 The reporter called to report about Twinrix vaccination.